髓样
液体活检
胎儿游离DNA
活检
生物
DNA甲基化
核糖核酸
癌症研究
细胞
甲基化
DNA
病理
基因
癌症
医学
基因表达
遗传学
怀孕
产前诊断
胎儿
作者
Maher Albitar,Hong Zhang,Ahmad Charifa,Andrew Ip,Wanlong Ma,James McCloskey,Michele Donato,David S. Siegel,Stanley Waintraub,Martin Gutierrez,Andrew Pecora,Andre Goy
出处
期刊:Heliyon
[Elsevier BV]
日期:2023-05-01
卷期号:9 (5): e16261-e16261
标识
DOI:10.1016/j.heliyon.2023.e16261
摘要
Current use of liquid biopsy is based on cell-free DNA (cfDNA) and the evaluation of mutations or methylation pattern. However, expressed RNA can capture mutations, changes in expression levels due to methylation, and provide information on cell of origin, growth, and proliferation status. We developed an approach to isolate cell-free total nucleic acid (cfDNA) and used targeted next generation sequencing to sequence cell-free RNA (cfRNA) and cfDNA as new approach in liquid biopsy. We demonstrate that cfRNA is overall more sensitive than cfDNA in detecting mutations. We show that cfRNA is reliable in detecting fusion genes and cfDNA is reliable in detecting chromosomal gains and losses. cfRNA levels of various solid tumor biomarkers were significantly higher (P < 0.0001) in samples from solid tumors as compared with normal control. Similarly, cfRNA lymphoid markers and cfRNA myeloid markers were all higher in lymphoid and myeloid neoplasms, respectively as compared with control (P < 0.0001). Using machine learning we demonstrate cfRNA was highly predictive of diagnosis (AUC >0.98) of solid tumors, B-cell lymphoid neoplasms, T-cell lymphoid neoplasms, and myeloid neoplasms. In evaluating the host immune system, cfRNA CD4:CD8B and CD3D:CD19 ratios in normal controls were as expected (median: 5.92 and 6.87, respectively) and were significantly lower in solid tumors (P < 0.0002). This data suggests that liquid biopsy combining analysis of cfRNA with cfDNA is practical and may provide helpful information in predicting genomic abnormalities, diagnosis of neoplasms and evaluating both the tumor biology and the host response.
科研通智能强力驱动
Strongly Powered by AbleSci AI